184 related articles for article (PubMed ID: 28883898)
1. Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
Kim TD; Oh S; Lightfoot SA; Shin S; Wren JD; Janknecht R
Int J Clin Exp Med; 2016; 9(6):10123-10134. PubMed ID: 28883898
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
3. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
Kim TD; Shin S; Janknecht R
Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
[TBL] [Abstract][Full Text] [Related]
4. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
Berry WL; Shin S; Lightfoot SA; Janknecht R
Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
[TBL] [Abstract][Full Text] [Related]
6. Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
Oh S; Shin S; Janknecht R
Int J Clin Exp Pathol; 2021; 14(7):795-810. PubMed ID: 34367411
[TBL] [Abstract][Full Text] [Related]
7. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
9. Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of
Sui Y; Jiang H; Kellogg CM; Oh S; Janknecht R
Front Oncol; 2023; 13():1122238. PubMed ID: 36890812
[TBL] [Abstract][Full Text] [Related]
10. Role of a 19S Proteasome Subunit- PSMD10
Sahu I; Nanaware P; Mane M; Mulla SW; Roy S; Venkatraman P
Int J Stem Cells; 2019 Nov; 12(3):463-473. PubMed ID: 31474027
[TBL] [Abstract][Full Text] [Related]
11. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
Li X; Moon G; Shin S; Zhang B; Janknecht R
Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
[TBL] [Abstract][Full Text] [Related]
13. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.
Shin S; Janknecht R
Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712
[TBL] [Abstract][Full Text] [Related]
14. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H
Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985
[TBL] [Abstract][Full Text] [Related]
15. A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation.
Verrier L; Escaffit F; Chailleux C; Trouche D; Vandromme M
PLoS Genet; 2011 Jun; 7(6):e1001390. PubMed ID: 21694756
[TBL] [Abstract][Full Text] [Related]
16. A druggable pocket on PSMD10
M G MS; Chikhale R; Nanaware PP; Dalvi S; Venkatraman P
Eur J Pharmacol; 2022 Jan; 915():174718. PubMed ID: 34953804
[TBL] [Abstract][Full Text] [Related]
17. Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role.
Mulla SW; Venkatraman P
Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311
[TBL] [Abstract][Full Text] [Related]
18. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway.
Cai X; Yu X; Tang T; Xu Y; Wu T
Mol Carcinog; 2024 May; ():. PubMed ID: 38818897
[TBL] [Abstract][Full Text] [Related]
19. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Kim TD; Shin S; Berry WL; Oh S; Janknecht R
J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
[TBL] [Abstract][Full Text] [Related]
20. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
Mallette FA; Richard S
Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
